Search clinical trials for: BNT162b2 vaccine
Total 9943 results
-
PfizerCompleted
-
BioNTech SECompletedCOVID-19 | SARS-CoV2 Infection | SARS-CoV-2 Acute Respiratory Disease | SARS (Disease)United States, Germany, Turkey, South Africa
-
BioNTech SEPfizerCompletedCOVID-19 | SARS-CoV-2 InfectionUnited States, Brazil, South Africa, Germany, Canada, Israel
-
University Hospital, Basel, SwitzerlandSwiss National Science Foundation; ModernaTX, Inc.CompletedImmunocompromised PatientsSwitzerland
-
BioNTech SEPfizerCompleted
-
Murdoch Childrens Research InstituteIndonesia University; Universitas Padjadjaran; Health Development Policy Agency... and other collaboratorsWithdrawn
-
Albert B. Sabin Vaccine InstituteStanford University; Aga Khan University; Oswaldo Cruz FoundationCompleted
-
Humanity & Health Medical Group LimitedCompleted
-
BioNTech SEPfizerCompletedCOVID-19 | SARS-CoV-2 InfectionUnited States, Germany, Turkey, South Africa, Argentina, Brazil
-
Murdoch Childrens Research InstituteCoalition for Epidemic Preparedness Innovations; The Peter Doherty Institute...Active, not recruiting
-
BioNTech SEActive, not recruitingRNA Virus Infections | Virus Diseases | Vaccine Adverse Reaction | Infection Viral | Infections, Respiratory | Protection Against COVID-19 and Infections With SARS CoV 2Germany
-
Universidad del DesarrolloPontificia Universidad Catolica de Chile; University of Chile; Ministry of Health...Active, not recruiting
-
PfizerCompletedCovid-19 | Immunocompromised | Breakthrough Infection | SARS-COV-2 Infection | SARS-COV-2 | ImmunosuppressedUnited States
-
Istanbul Medeniyet UniversityCompleted
-
Assistance Publique - Hôpitaux de ParisCOVIREIVACActive, not recruitingAdult Who Received a First Dose of an mRNA Vaccine (Pfizer-BioNTech or Moderna) and Need to Receive a Second DoseFrance
-
National Institute of Allergy and Infectious Diseases...Completed
-
National Institute of Allergy and Infectious Diseases...CompletedCOVID-19United States
-
Canadian Immunization Research NetworkMassachusetts General Hospital; CHU de Quebec-Universite Laval; McGill University... and other collaboratorsActive, not recruiting
-
Mebo Research, Inc.AurametrixActive, not recruitingCOVID-19 VaccinesUnited States, Georgia, Kenya, United Kingdom
-
The University of Hong KongActive, not recruiting
-
University Medicine GreifswaldActive, not recruiting
-
BioNTech SEPfizerCompletedSARS-CoV-2 Infection, COVID19United States, Brazil, Germany, Mexico
-
BioNTech SEPfizerCompletedCOVID-19 | SARS-CoV-2 InfectionAustralia, New Zealand
-
Assistance Publique - Hôpitaux de ParisCOVIREIVACActive, not recruiting
-
Universiteit AntwerpenCompletedCOVID-19 | Coronavirus Disease 2019Belgium
-
Masaryk UniversityRecruitingAdverse Reaction to Vaccine | COVID19 VaccinePoland, Canada, United States, Croatia, Czechia, Estonia, Ethiopia, Germany, Ghana, Mexico, Portugal, Russian Federation, Serbia, Slovenia
-
National Institute of Allergy and Infectious Diseases...Rho Federal Systems Division, Inc.; Autoimmunity Centers of ExcellenceCompletedSystemic Lupus Erythematosus (SLE) | Multiple Sclerosis (MS) | Rheumatoid Arthritis (RA) | Juvenile Dermatomyositis (JDM) | Juvenile Idiopathic Arthritis (JIA) | Pemphigus Vulgaris | Systemic Sclerosis (SSc) | Pediatric SLE | Pediatric-Onset Multiple Sclerosis (POMS)United States
-
National Institute of Allergy and Infectious Diseases...Rho Federal Systems Division, Inc.; Immune Tolerance Network (ITN)CompletedCOVID-19 | SARS-CoV Infection | Allergic Reaction | Mast Cell DisorderUnited States
-
PfizerCompletedCOVID-19 | SARS-CoV-2 InfectionAustralia, New Zealand
-
BioNTech SEPfizerCompletedCOVID-19 | SARS-CoV-2 Infection | Maternal ImmunizationUnited States, United Kingdom, Spain, Brazil, South Africa
-
Murdoch Childrens Research InstituteCoalition for Epidemic Preparedness Innovations; The Peter Doherty Institute...Completed
-
BioNTech SEPfizerCompletedCOVID-19 | SARS-CoV-2 InfectionJapan
-
BioNTech SEPfizerCompletedCOVID-19 | SARS-CoV-2 InfectionUnited States
-
PfizerCompletedCOVID-19 | Pneumococcal Disease | SARS-CoV-2 InfectionUnited States
-
BioNTech SECompletedCOVID-19 | SARS-CoV-2 InfectionGermany
-
Chang Gung Memorial HospitalMedigen Vaccine Biologics Corp.Active, not recruitingCOVID-19 | Breakthrough InfectionTaiwan
-
BioNTech SEShanghai Fosun Pharmaceutical Industrial Development Co. Ltd.Completed
-
Shaare Zedek Medical CenterCompletedCOVID-19 | Myocardial Injury | Vaccine Adverse ReactionIsrael
-
Royal College of Surgeons in Ireland - Medical...Ministry of Health, Bahrain; The National Taskforce for Combatting COVID-19-... and other collaboratorsCompletedCovid19 | SARS-CoV 2 InfectionBahrain
-
BioNTech SEPfizerCompletedSARS-CoV-2 Infection, COVID-19United States, Spain, Finland, Poland, Mexico, Brazil
-
National and Kapodistrian University of AthensRecruitingCOVID-19 | Chronic Disease | Solid Tumor | Healthy Volunteers | Hematological MalignanciesGreece
-
The University of Hong KongActive, not recruiting
-
BioNTech SEPfizerWithdrawn
-
Murdoch Childrens Research InstituteCoalition for Epidemic Preparedness Innovations; The Peter Doherty Institute...Withdrawn
-
BioNTech SEPfizerRecruitingCOVID-19 | Severe Acute Respiratory Syndrome Coronavirus 2 | SARS-CoV-2 VirusUnited States, South Africa, Brazil, Puerto Rico
-
TakedaCompletedParkinson's DiseaseJapan
-
The University of Hong KongActive, not recruiting
-
PfizerCompleted
-
The University of Hong KongRecruitingImmunocompromised Patients | Intradermal Covid-19 Vaccine | Immungenicity and Safety | Randomized TrialHong Kong